Law firm · Italy

Gatti Pavesi Bianchi Ludovici

Deals
2
Latest
May 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

2 of 2 deals

Deals Gatti Pavesi Bianchi Ludovici advised on, most recent first
Advisers
May 2026 Catalyst Pharmaceuticals –Angelini Pharma S.p.A.AcquisitionLegal adviser to Angelini Pharma S.p.A. (acquirer)Pending4,100.0Pharma+1 Centerview Partners (buy-side)BNP Paribas (buy-side)Morgan Stanley (buy-side)Hogan Lovells Cadwalader (buy-side)J.P. Morgan (sell-side)Kirkland & Ellis (sell-side)Akerman (sell-side) Angelini Pharma S.p.A. acquisition of Catalyst Pharmaceuticals
Aug 2025 Tinexta S.p.A. Tecno Holding S.p.A.Advent InternationalAcquisitionLegal adviser to Tecno Holding (seller)Completed–Software+2 Rothschild & Co (buy-side)Barclays (buy-side)Banca Akros (buy-side)Alvarez & Marsal (buy-side)Legance (buy-side)KPMG (buy-side)Lazard (sell-side)Chiomenti (buy-side)PedersoliGattai (buy-side) Advent International acquisition of Tinexta S.p.A.

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.